| abstract |
The current registration relates to a new heterocylically substituted, anellated pyrazole derivative, and a process for its manufacture, its use by itself or in a combination to treat and/or prevent diseases as well as its use in the manufacture of medical drugs for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of cardiovascular illnessesdiseases. |